| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 896 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 280 | 2021 |
| Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages T Vieira, M Antoine, C Hamard, V Fallet, M Duruisseaux, N Rabbe, ... Lung Cancer 98, 51-58, 2016 | 129 | 2016 |
| Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study CH Marquette, J Boutros, J Benzaquen, M Ferreira, J Pastre, C Pison, ... The Lancet Respiratory Medicine 8 (7), 709-716, 2020 | 111 | 2020 |
| High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets V Fallet, R Saffroy, N Girard, J Mazieres, S Lantuejoul, T Vieira, ... Annals of Oncology 26 (8), 1748-1753, 2015 | 99 | 2015 |
| Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung T Vieira, M Antoine, AM Ruppert, V Fallet, M Duruisseaux, EG Leprieur, ... Lung cancer 85 (2), 276-281, 2014 | 87 | 2014 |
| Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer J Cadranel, A Canellas, L Matton, M Darrason, A Parrot, JM Naccache, ... European Respiratory Review 28 (153), 2019 | 85 | 2019 |
| Prospective screening for ALK: clinical features and outcome according to ALK status V Fallet, J Cadranel, H Doubre, C Toper, I Monnet, T Chinet, G Oliviero, ... European journal of cancer 50 (7), 1239-1246, 2014 | 64 | 2014 |
| Lung cancer is also a hereditary disease PR Benusiglio, V Fallet, M Sanchis-Borja, F Coulet, J Cadranel European Respiratory Review 30 (162), 2021 | 63 | 2021 |
| MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung R Saffroy, V Fallet, N Girard, J Mazieres, DM Sibilot, S Lantuejoul, ... Oncotarget 8 (26), 42428, 2017 | 56 | 2017 |
| c-MET overexpression as a poor predictor of MET amplifications or exon 14 mutations in lung sarcomatoid carcinomas X Mignard, AM Ruppert, M Antoine, J Vasseur, N Girard, J Mazieres, ... Journal of Thoracic Oncology 13 (12), 1962-1967, 2018 | 52 | 2018 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| Percutaneous image-guided electrochemotherapy of spine metastases: initial experience FH Cornelis, M Ben Ammar, M Nouri-Neuville, L Matton, MA Benderra, ... CardioVascular and Interventional Radiology 42, 1806-1809, 2019 | 28 | 2019 |
| Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer A Costantini, J Corny, V Fallet, S Renet, S Friard, C Chouaid, ... ERJ open research 4 (2), 2018 | 26 | 2018 |
| Brief report: severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti–programmed cell death (Ligand) 1 and sotorasib therapy in … A Chour, J Denis, C Mascaux, M Zysman, L Bigay-Game, A Swalduz, ... Journal of Thoracic Oncology 18 (10), 1408-1415, 2023 | 25 | 2023 |
| Secondary resistance to erlotinib: acquired T790M mutation and small-cell lung cancer transformation in the same patient V Fallet, AM Ruppert, V Poulot, R Lacave, L Belmont, M Antoine, ... Journal of Thoracic Oncology 7 (6), 1061-1063, 2012 | 24 | 2012 |
| Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives EG Leprieur, V Fallet, J Cadranel, M Wislez Lung Cancer: Targets and Therapy, 83-90, 2016 | 23 | 2016 |
| RET-MAP: An international multicenter study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion M Aldea, A Marinello, M Duruisseaux, W Zrafi, N Conci, G Massa, G Metro, ... Journal of Thoracic Oncology 18 (5), 576-586, 2023 | 19 | 2023 |
| Nivolumab-refractory patients with advanced non-small-cell lung cancer A Costantini, V Fallet, J Corny, S Friard, C Chouaid, B Duchemann, ... Lung Cancer 130, 128-134, 2019 | 18 | 2019 |
| Pulmonary sarcomatoid carcinoma M Antoine, T Vieira, V Fallet, C Hamard, M Duruisseaux, J Cadranel, ... Annales de Pathologie 36 (1), 44-54, 2016 | 16 | 2016 |
